0
SCFAs acetate, propionate, and butyrate increased in all patients treated with 2 0 7
FMT, reaching similar levels as observed in the donor (Fig. 5 ). Processing the 2 0 8 fecal material (homogenization and filtering) decreased levels of the SCFAs 2 0 9 measured. Levels of succinate and lactate, which can be used by some bacteria 2 1 0 as substrates for the production of propionate and butyrate respectively, 2 1 1 remained unchanged in most patients treated with FMT (Fig. S3 ). Although we observed generalizable patterns of microbial community and 2 1 6 metabolite recovery in patients receiving FMT, intra-individual similarity was higher compared to inter-individual similarity following FMT, suggesting some 2 1 8 individuality of microbiota recovery over time (Fig 2A) . To identify OTUs that 2 1 9 associated with the levels of individual metabolites, while accounting for 2 2 0 clustered (intra-individual), repeated measurements over time, we built 2 2 1 multivariable mixed models using generalized estimating equations (GEEs) (25).
2
This approach takes into account longitudinal changes within subjects while still were most impacted by FMT within recipients over time: the primary bile acids CA, TCA, TCDCA, the secondary bile acids DCA and LCA, and the SCFAs OTUs were positively correlated with SCFAs and secondary bile acids and 2 3 4 negatively correlated with primary bile acids (Fig. 6) Proteobacteria were negatively correlated with the secondary bile acid LCA. Our results demonstrate individualized recovery of the microbiome recipients, suggesting that secondary bile acid production throughout recovery 2 4 6 may be more dynamic.
4 7
In our study, we observed that the majority of OTUs detected in recipients sequencing is not robust enough to distinguish strain-level differences between 2 5 5 microbes, our results support observations made in studies that have used more 2 5 6 discrete methods to identify bacteria that colonize following FMT. A recent study 2 5 7 using genomes assembled from metagenomic data to distinguish more species- Bacteroidales, but not Clostridiales, were more likely to colonize individuals (26). were able to transplant recipients from the donor (27). However, strain 2 6 4 dominance and resilience was not consistently observed across patients, suggesting at least some individuality in acceptance of transplanted species. These studies, along with our results, support the observation that although 2 6 7 transfer may occur during FMT, it is likely to be stochastic or donor-recipient 2 6 8 dependent.
6 9
One of the key questions about FMT efficacy for recurrent CDI and other species, or 'engraftment', is even necessary for successful treatment outcome. Other studies using 16S rRNA sequencing of the microbiota in patients with CDI necessarily translate to a successful outcome (24, 28 Regardless of the source of transplanted microbes, recovery from CDI is leading hypothesis for resistance is the ability of the gut microbiota to convert 2 9 1 primary bile acids, which include known germinants of C. difficile spores, into 2 9 2 secondary bile acids, which are known to inhibit C. difficile growth in vitro (12, 2 9 3 16). Our data in human patients supports this trend; however, levels of 2 9 4 secondary bile acid recovery were variable across individuals. Variation in the 2 9 5 levels of detected bile acids following FMT in patients has also been observed in properties of secondary bile acids are able to shape the recovering microbiota 3 0 7 (34). In addition to general shifts in bile acids, we observed full recovery of the 3 0 9
SCFAs acetate, propionate, and butyrate following FMT. In particular, the role of been associated with CDI in humans (37) and butyrate has been shown to limit 3 1 3 expansion of the intestinal pathogen Salmonella enterica in the mouse gut (38). Little is known about the synergistic effects of bile acids and SCFAs, but the metabolically active community, which may be critical to maintaining resistance 3 1 7 to C. difficile. Not surprisingly, related microbes were found to correlate with 3 1 8 increases in both bile acids and short chain fatty acids following FMT in our 3 1 9 study. It is possible that in cases where community recovery is observed but has a lower success rate (39).
2 4
In summary, we observed variable direct transfer between donor-recipient present in a microbiome resistant to colonization resistance against C. difficile,
elucidating specific factors that potentially mediate clearance. were over 18 and not pregnant. Recipients had experienced at least two informed consent, FMT recipients were asked to collect six fecal samples using a prior to the procedure (1-2 weeks and 1-2 days before), and four samples 3 4 8
following the procedure (1-2 days, 1-2 weeks, 1-2 months, and 6 months after). immediately frozen, collected as described above, and one sample processed as at home, and bring the sample to the hospital at room temperature. Prior to the procedure, the donor material was diluted 1:1 again with sterile saline solution.
5 7
Large particular matter was then filtered out until the solution was of a overnight, and had nothing by mouth starting the morning of the procedure. Standard colonoscopy was performed and the FMT material was then and remained symptom free until the last patient contact at 6 months post-FMT. PCR amplification of the 16S V4 region, using uniquely barcoded dual index #12346094), with 1 μ l template. PCR cycling conditions were ran at 95°C (2 min), followed by 30 cycles of (95°C (20 sec), 55°C (15 sec), and 72°C (5 min)), and Technologies, #A10510-01) before pooling, then quantified with the Kapa
Biosystems Library Quantification kit for Illumina (KapaBiosystems, #KK4854).
The Agilent Bioanalyzer high-sensitivity DNA analysis kit (#5067-4626) was used 3 8 2 to determine amplicon size. Sequencing was conducted using the MiSeq (BioSamples SAMN06842879−SAMN06842922). samples were kept on ice for 10 min and centrifuged at 45°C at 13000 rpm for 10
min. Supernatant containing metabolites were transferred to another tube and two steps were combined and dried under vacuum at 45°C by using a vacuum
centrifuge. Dried samples were reconstituted in 50:50 methanol/water for LC-MS analysis. A series of calibration standards were prepared and analyzed along temperature was isocratic at 310°C. Data were processed using MassHunter
Quantitative analysis version B.07.00. SCFAs were normalized to the nearest 4 2 5 isotope labeled internal standard and quantitated using 2 replicated injections of analyses, with UCHIME to remove chimeras (42). The SILVA rRNA database shared OTU percentages in donor-recipient pairs, and abundance of metabolites. post-FMT samples within that individual at the specified time points (pre-vs. OTUs and metabolite coefficients was generated using gplots (45). A metabolites was generated by aligning the specified OTUs in mother using the concentrations over time. GEE models were constructed in R using the package Clostridium difficile infection in the United States. N Engl J Med 372:825-34. vancomycin. Clin Infect Dis 55 Suppl 2:S154-61. Gastroenterol 48:693-702. Microbes 4:125-35. One 8:e81330. 
